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Colon cancer patients routinely undergo preoperative computed tomography (CT) scanning, but local staging is thought to be
inaccurate. We aimed to determine if clinical outcome could be predicted from radiological features of the primary tumour.
Consecutive patients at one hospital undergoing primary resection for colon cancer during 2000–2004 were included. Patients with
visible metastases were excluded. Preoperative CT scans were reviewed independently by two radiologists blinded to histological
stage and outcome. Images of the primary tumour were evaluated according to conventional TNM criteria and patients were
stratified into ‘good’ or ‘poor’ prognosis groups. Comparison was made between prognostic group and actual clinical outcome.
Hundred and twenty-six preoperative CT scans were reviewed. T-stage and nodal status was correctly predicted in only 60 and 62%,
respectively. However, inter-observer agreement for prognostic group was 79% (k¼0.59) and 3-year relapse-free survival was 71
and 43% for the CT-predicted ‘good’ and ‘poor’ groups, respectively (Po0.0066). This compared favourably with 75 vs 43% for
histology-predicted prognostic groups. Computed tomography is a robust method for stratifying patients preoperatively, with similar
accuracy to histopathology for predicting outcome. Recognition of poor prognosis tumours preoperatively may permit investigation
into the future use of neo-adjuvant therapy in colon cancer.
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Colorectal adenocarcinoma is the third commonest cancer in the
United Kingdom, with 35000 new cases discovered every year and
16000 deaths resulting annually (Scottish Cancer Registry, 2005;
Northern Ireland Cancer Registry, 2005; Office for National
Statistics, 2005; Welsh Cancer Intelligence and Surveillance Unit,
2006). Approximately 70% of cases involve the colon, the
remaining 30% involving the anus and rectum. Knowledge of the
extent of the primary tumour at initial diagnosis is critical for
proper management of disease as the prognosis for patients
diagnosed with colon cancer is directly related to stage at
presentation. In the UK, most patients with colon cancer undergo
preoperative staging with abdomino-pelvic computed tomography
(CT) scanning, but this is carried out in order to diagnose or
exclude the presence of synchronous metastases, rather than to
evaluate the characteristics of the primary tumour itself.
Primary surgery is accepted to be the only potentially curative
treatment for colonic cancer. Unlike rectal cancer, where
preoperative neoadjuvant therapy has been used with considerable
success, there is currently no role for preoperative therapy in colon
cancer. Adjuvant radio- or chemotherapy may be offered post-
surgery to patients with advanced-stage tumours, as defined by
histological staging criteria.
Previous studies examining the usefulness of preoperative CT
for staging of colon cancer have judged its ‘accuracy’ by
comparisons with histology (Freeny et al, 1986; Balthazar et al,
1988; Acunas et al, 1990; Hundt et al, 1999). Although tumour
staging has its origins in the histological description of colorectal
cancers (Dukes, 1932), its rationale is in the stratification of
patients into prognostic categories. It may be argued, therefore,
that the value of preoperative staging should not be judged solely
according to its ability to predict histology, but also according to
its ability to predict outcome. We are not aware of any previous
studies that have examined the correlation between CT-based
staging and outcome. Therefore, we have designed a study to
examine this.
Aims
1. To examine whether the radiological features of the primary
colonic tumour seen on the preoperative CT scan could be used
to predict clinical outcome.
2. To compare preoperative CT-based prognostication with post-
operative histology (the current ‘gold’ standard).
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sMATERIALS AND METHODS
The medical records of all 312 consecutive patients undergoing
resection of a colonic carcinoma (defined as any tumour above the
peritoneal reflection) at Mayday Hospital between January 2000
and December 2004 were retrospectively reviewed. Of these, 201
had preoperative CT-staging performed. Any patients with visible
metastases were excluded, as were those patients who had
undergone any preoperative radiotherapy or chemo-radiotherapy.
For each eligible patient, information on the patient’s age, sex and
tumour site was recorded. Carcinomas were staged pathologically
according to the Royal College of Pathologists guidelines (Quirke
and Williams, 2000) and used the TNM classification (Sobin and
Wittekind, 2002) (Table 1). This information was obtained from
the original pathology report located in the patient’s medical notes.
The X-ray filing libraries were searched, and the original
preoperative CT scans were retrieved.
Review of CT images
All available preoperative CT films were reviewed independently
by two consultant radiologists (NB and GB), both of whom had
been involved in previous CT/MRI comparative studies and were
experienced with CT-based staging. Each observer was blinded to
the final histological stage and clinical outcome. Images of the
primary tumour were evaluated using a dedicated proforma
(Figure 1) taking into account patterns of local spread derived
from previous histological studies as well as conventional TNM
assessment (Sobin and Wittekind, 2002).
T- and N-stage The primary tumour was assessed for T-stage.
Patients were stratified into ‘good’ or ‘poor’ prognosis groups
based on CT-predicted T-stage. Early T3 tumours with predicted
extramural invasion up to 5mm were labelled ‘T3good’ (corre-
sponding to pT3a/pT3b). These together with T1/T2 tumours were
stratified into the same favourable prognostic group. More
advanced T3 tumours (labelled ‘T3bad’) that appeared to show
extramural invasion more than 5mm beyond the muscle coat
(corresponding to pT3c/pT3d) and T4 tumours with suspected
involvement or perforation of the visceral peritoneum or direct
invasion of an adjacent organ were considered to have a poor
prognosis.
In addition, the images were assessed for evidence of lymph
node involvement. Lymph nodes were considered to be involved
by tumour when they were enlarged or had irregular borders.
Table 1 Definitions of TNM components in the 6th edition of the AJCC and UICC system for staging cancer of the colon and rectum, 2002 (Sobin and
Wittekind, 2002)
Category Description
TX The primary tumour cannot be assessed
T0 No evidence of primary tumour
Tis Carcinoma in situ (intraepithelial or intramucosal carcinoma)
T1 Tumour invades into the submucosa
T2 Tumour invades into the muscularis propria
T3 Tumour invades through the muscularis propria into the subserosa, or into nonperitonealised pericolic or perirectal tissues
Optional subdivision of T3
T3a Minimal invasion: o1mm beyond the border of the muscularis propria
T3b Slight invasion: 1–5mm beyond the border of the muscularis propria
T3c Moderate invasion: 45–15mm beyond the border of the muscularis propria
T3d Extensive invasion: 415mm beyond the border of the muscularis propria
T4 Tumour directly invades into other organs or structures (T4a) or perforates the visceral peritoneum (T4b)
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastases
N1 Metastatic tumour in 1–3 pericolic or perirectal lymph nodes
N2 Metastatic tumour in four or more pericolic or perirectal lymph nodes
MX The presence of distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis present
Preoperative CT colon vs outcome study
data collection proforma
Patient name
Hosp. number Scan date
Reviewed by Review date
Primary tumour site (circle predominant location) 
Hepatic flexure Transverse colon Splenic flexure 
Ascending colon Descending colon 
Caecum Sigmoid 
Rectosigmoid 
Staging (circle predicted TN stage)
(NB exclude patients with any evidence of distant metastases) 
T-stage: Tx T1/T2 T3good* T3bad** T4
(*good=extramural depth  5 mm; **bad=extramural depth>5 mm) 
N-stage: N0 N1
Confidence scale of lymph node assessment
nodes visible ?significance
N2
No visible  Enhancing/irregular 
nodes   node(s)
01234
Evidence of extramural vascular invasion: (circle)
absent   
Definitely
present
Definitely
01234
General impression of prognosis
Good    Bad 
01234
why?
Figure 1 Data collection proforma for CT colon study.
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sOverall ‘prognostic score’ A five-point linear scale based on
assessment of all the radiological features was used in assigning an
overall prognostic score (PS) for each patient.
Outcome analysis
Prospectively compiled clinical follow-up information was re-
corded from the medical notes. The date and nature of any disease
recurrence (local or distant) was documented and if the patient
had died, the date and cause of death. Because the median duration
of clinical follow-up was relatively short, relapse-free survival
(RFS) was chosen as the outcome measure. Death from any cause
and recurrence of colorectal cancer or development of a new
colorectal primary tumour were counted as events.
Outcome analysis was performed based on each of the following:
histological criteria (Table 2); CT-predicted T-stage; CT-defined
PS. For each outcome analysis, patients were allocated into one of
two prognostic groups (‘good’ or ‘poor’).
Statistical analysis
Kaplan–Meier survival curves were used for interpretation of the
outcome data. k coefficients were used in the measurement of
interobserver agreement.
RESULTS
Patient demographics
During the 5 years between January 2000 and December 2004, 312
patients underwent resection for carcinoma of the colon. Of these,
201 had a preoperative CT scan within a median of 25 days of their
operation. Twenty-eight patients had visible metastases on the
original CT report, 12 patients had undergone preoperative
radiotherapy and one other had an incidental caecal carcinoma
resected at laparotomy for an appendix mass. These 40 patients
were all excluded. One hundred and twenty six out of 161 (78.3%)
scans from 63 men and 63 women were available for review
(Figure 2). The median age at operation was 74 years (range 33–89
years).
At the point of survey, 87 patients (69.0%) were still alive, with a
median follow-up time since operation of 2.68 years (range¼10
months to 6.25 years).
Accuracy of CT staging
T- and N-stage At histopathological examination, seven (5.6%) of
126 tumours were staged as pT1, 13 (10.3%) as pT2, 67 (53.1%) as
pT3 and 39 (31.0%) as pT4.
The overall accuracy of stage-for-stage prediction of T-stage was
60.3 and 60.8% for observer A and B, respectively (Table 3). For
the correct recognition of extramural tumour invasion (stage pT3
or pT4), observer A was 83.3% accurate compared with histology
(92.4% sensitivity; 42.1% specificity; positive predictive value
(PPV) 89.8%). Observer B achieved 76.2% accuracy with
Table 2 Prognostic categorisation of primary tumour according to
histology
Histological variable ‘Good’ prognosis ‘Poor’ prognosis
T-stage T1, T2 or T3 T4
N-stage N0 N1 or N2
EMVI Absent Present
Distant metastases
a Absent Present
(e.g., peritoneal seedlings)
aThe presence of visible metastases was an exclusion criterion for the study. In a very
few cases; however, peritoneal seedlings were only identified at operation.
312 Consecutive 
patients undergoing 
resection of colonic 
cancer 2000–2004 
161 
Eligible 
patients
28 Synchronous 
metastases (27 
hepatic, 1 ovarian)
111 no pre-
operative CT 
performed 
126 Patients 
40 Exclusions 
1 Appendix 
mass 
(incidental 
carcinoma) 
11 Preop 
therapy (8 CRT, 
2 LRT, 1 SRT) 
35 Scans 
not found 
15 Emergency  111 Elective 
Figure 2 Flowchart for patient selection into study.
Table 3 CT-predicted T stage for each observer vs histology T stage
Observer A CT-predicted T-stage Observer B CT-predicted T stage
Histology T1/T2 T3good T3bad T4 Tx Total T1/T2 T3good T3bad T4 Tx Total
T1 4 2 1 7 5 2 7
T2 4 6 2 1 13 6 1 6 13
T3 7 26 18 15 1 67 12 14 26 9 6 67
T4 1 4 10 24 39 2 4 7 25 38
Total 16 38 30 40 2 126 25 19 39 34 8 125
Observer A: Stage-for-stage accuracy¼60.3%. Extramural invasion (stage T3/T4): Overall accuracy¼83.3% (sensitivity¼92.4%; specificity¼42.1%). Positive predictive
value¼89.8%; negative predictive value¼50.0%. Observer B: Stage-for-stage accuracy¼60.8%. Extramural invasion (stage t3/t4): Overall accuracy¼76.2% (sensitivity¼85.9%;
specificity¼61.1%). Positive predictive value¼92.4%; negative predictive value¼44.0%.
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respectively. Figures 3–6 show examples of CT scans evaluated.
Eighty-six (68.3%) of 126 tumours were staged by pathology as
pN0, 27 (21.4%) as pN1 and 13 (10.3%) as pN2. The overall
accuracy of stage-for-stage prediction of N stage was poor (50.4
and 54.8% for observer A and B, respectively), but for lymph node
status (involved or tumour-free), accuracy was slightly better at
61.8 and 62.1% for each observer.
Using the criteria described in Table 2, patients were categorised
as having either ‘good’ or ‘poor’ prognosis tumours based on their
histological staging. Seventy-one out of 126 (56.3%) patients had
tumours categorised histologically as poor prognosis.
Prognostic group based on CT T-stage vs histology The best
correlation between CT-predicted T-stage prognostic group and
histology-predicted group showed an overall accuracy of 71%
(sensitivity 73%; specificity 67%), with a PPV (for ‘poor’
prognosis) of 74%. There was 79.2% agreement (k¼0.59) between
the observers on reporting of advanced T3c/d and T4 tumours
(Table 4).
Prognostic group based on overall ‘PS’ vs histology The subjective
PS (0–4) was also used to assign patients into prognostic
categories, with PS¼0–2 corresponding to a ‘good’ PS, and
PS¼3–4 a ‘bad’ score. Correlating PS-based prognostic group
with histology-based group, observer A achieved the highest
Figure 3 Preoperative CT scan showing a polypoid tumour of the
descending colon extending into the lumen (black arrowheads). Tumour
does not extend beyond the contour of the muscle coat indicating that this
is an early T1/T2 tumour. Pathological staging was pT2.
Figure 4 Preoperative CT scan showing a fungating tumour of the
ascending colon. The colonic wall is thickened and the posterior contour is
irregular owing to tumour projection beyond the non-peritonealised
muscle coat. As there is no tumour involvement of the peritonealised
surfaces, this is considered a relatively good prognosis T3 tumour.
Pathology confirmed a pT3 tumour of the ascending colon.
Figure 5 Preoperative CT scan showing a fungating tumour of the
transverse colon. The anterior colonic wall is distorted by tumour. As there
is minimal pericolic fat and the colon is peritonealised at this location, there
is a very high probability that the tumour will be stage T4. Pathological
staging was pT4pN1.
Figure 6 Preoperative CT scan showing a bulky tumour of the
descending/sigmoid junction. There is irregular nodular extension medially
(arrows) indicating T3 infiltration. This is likely to extend through the medial
nonperitonealised, mesenteric surface of the colon. The pathological stage
was confirmed as pT3.
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(for ‘poor’ prognosis) of 72%. Inter-observer agreement for PS-
based prognostic group was 80% (k¼0.60).
Prediction of outcome
Kaplan–Meier survival curves were constructed to illustrate
differences in outcome between prognostic groups. As the median
length of recorded follow-up was just under 3 years, RFS was
chosen as the preferred outcome measure.
Histology Three-year RFS for patients with ‘good’ prognosis
tumours according to histology was 75% (95% confidence interval
(CI): 60–86%) vs 43% (30–45%) for ‘poor’ prognosis tumours
based on histology (Po0.00001, Figure 7).
Predicted CT T-stage Three-year RFS for patients with CT-based
‘good’ prognosis tumours was 71% (95% CI: 55–82%) compared
with 43% (34–60%) in ‘poor’ tumours for observer A (P¼0.0066).
This compared with 66% (51–75%) vs 49% (34–63%) for observer
B( P¼0.0475, Figure 8).
Overall CT PS Three-year RFS for patients with ‘good’ PS (0–2)
was 70% (95% CI: 54–81%) compared with 48% (35–60%) for
patients with ‘poor’ PS (3–4) for observer A (P¼0.0091, Figure 9).
This compared with 63% (50–74%) vs 52% (37–65%) for observer
B( P¼0.1655).
DISCUSSION
Knowledge of the extent of disease at initial diagnosis is critical for
the proper management of patients with colorectal cancer. Several
authors have found that preoperative CT provides useful
information in up to half and definitely alters clinical management
in around 20% of patients with colon cancer (Kerner et al, 1993;
Barton et al, 2002; Mauchley et al, 2005) and most often this relates
to the detection of liver metastases. In our series, we excluded
patients with preoperatively detected distant metastases in order to
investigate whether, contrary to conventional wisdom, preopera-
tive CT staging could be useful in predicting outcome in the
majority of patients who do not have metastatic disease. No other
published series has compared CT-predicted tumour stage with
clinical outcome.
We were careful to apply the accepted pathological TNM
definitions of T-stage (Table 1) to CT staging. The overall accuracy
of T-stage prediction by each of our observers was 60.3 and 60.8%
compared with histology, whereas identification of T3/T4 tumours
was 85.9–92.4% sensitive, with a PPV of at least 90–92%. These
results appear to compare favourably with other studies, which
have reported sensitivities of between 55 and 61% and specificities
of 67–81% in the detection of ‘serosal’, ‘extramural’ or ‘local (T3–
T4) invasion (Freeny et al, 1986; Acunas et al, 1990; Zerhouni et al,
1996). However, this relative lack of definition of depth of invasion
makes direct comparison between those studies and our own
results difficult. Newer multi-slice/spiral-CT scanners, which are
able to collect 1-mm thick slices, within a single breath hold
permitting 3D reconstruction, give improved resolution and image
quality. Two small series using CT colonography (‘virtual
colonoscopy’) have produced good results, with correct T-staging
reported in 26 (78.7%) of 33 and 30 (81%) of 37 colorectal tumours
(Hundt et al, 1999; Laghi et al, 2002).
The reported sensitivities for lymph node detection range
between 19 and 97% (Freeny et al, 1986; Acunas et al, 1990;
Zerhouni et al, 1996; McAndrew and Saba, 1999; Laghi et al, 2002).
Table 4 Agreement of CT-predicted good/poor prognosis T stage
(Observer A vs observer B)
Observer A
Observer B T1/2, T3good T3bad, T4
T1/2, T3good 48 21
T3bad, T4 5 51
Inter-observer agreement¼79% (k¼0.59).
Outcome according to histology
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Figure 7 Kaplan–Meier RFS curves according to histological group.
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Figure 8 Kaplan–Meier RFS curves according to CT-predicted T-stage.
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well known – small/normal-sized nodes may have microscopic
tumour infiltration, whereas, occasionally, very large nodes may be
reactive, rather than malignant. In our series, lymph node status
was accurately predicted by each of the two observers in 61.8 and
62.1%, respectively. Consequently, we have not found CT to be
particularly useful in the assessment of lymph nodes.
Most published series have emphasised the value of preoperative
CT staging to diagnose metastatic disease (Freeny et al, 1986;
Balthazar et al, 1988; Acunas et al, 1990; Kerner et al, 1993; Thoeni,
1997). Many have concluded that preoperative CT staging is of
little value other than to exclude distant metastases because of its
limited accuracy, particularly in staging early tumours (Thoeni,
1997). Clearly, no imaging modality that evaluates gross morphol-
ogy (such as CT) will ever be as ‘accurate’ as the microscope.
Nevertheless, although it is undoubtedly true that CT does not
‘accurately’ measure depth of invasion in early-stage tumours, this
is not usually of great clinical significance. The clinical outcome
for patients with early-stage (T1-2, N0) colonic tumours is usually
excellent (5-year overall survival 80–95%). In contrast, patients
with locally advanced T4 tumours have a much poorer outcome
and some histological studies have also identified extramural
invasion greater than 5mm (T3c/d) as a poor prognostic feature
(Merkel et al, 2001) and we have recognised this in our
categorisation of CT-predicted T-stage. Currently, patients with
poor prognostic features on histology may be offered post-
operative adjuvant systemic chemotherapy. Identification of
patients with locally advanced colonic tumours preoperatively
would be of great importance if preoperative neo-adjuvant
therapies were to be considered. We have applied the lessons
learnt from using MRI to assess the surgical anatomy of the rectum
to our CT-based assessment of colonic tumours. Knowledge of the
surgical anatomy of the colon and specifically the distribution of
peritonealised and nonperitonealised surfaces has enabled us to
improve our assessment of the depth of invasion, the presence of
T4 disease (peritoneal perforation) and potential resectability.
This study is interesting because it highlights the heterogeneity
of actual clinical outcomes for different pathological stages.
Pathological criteria are widely accepted as the basis for
prognostication (and therefore as an indication for adjuvant
therapy) because there is an abundance of evidence that correlates
pathology with outcome for populations. However, within a
population of patients, some with ‘good’ prognosis tumours will
relapse and some with ‘poor’ prognosis tumours will do well,
having been cured by surgery alone, receiving no extra benefit
from their adjuvant chemotherapy. In our study, the RFS at 3 years
for patients with no adverse pathological features was 75 compared
with 43% for those with one or more poor prognosis feature
(Po0.00001). There is to date no other published study that has
directly compared preoperative CT staging of the primary tumour
with clinical outcome, but our study does appear to show that CT
can also discriminate between ‘good’ and ‘poor’ prognosis
tumours, with similar ‘accuracy’ to pathology. Not every ‘poor’
tumour relapses and not every ‘good’ tumour remains disease free,
but an overall trend is seen in the population and the 3-year RFS
based on CT predicted T-stage criteria was 71 vs 43% (Po0.0066).
The fact that the CT-stage may not correlate exactly to the
pathological stage is therefore of less importance as the CT stage
predicts outcome as well as pathology for the population.
We attempted to produce an overall PS taking into account all
visible features (namely T-stage, nodal status and extramural
vascular invasion). We found that this was actually less
discriminating than CT-predicted T-stage alone, and the prog-
nostic accuracy of T-stage alone was diluted, rather than enhanced
by the combination of other features. We believe that the
inaccuracy of CT assessment of lymph node status was the major
contributory factor, together with the lack of precise objectivity in
defining the criteria for the five-point PS, which would limit
reproducibility. We therefore do not recommend the use of such a
score in its present form.
High sensitivity rates are desirable to enable the potential
therapeutic benefit of preoperative treatments to be offered to as
many appropriate individuals as possible. However, particularly
from the point of view of clinical trials, high PPVs are of even
greater importance to avoid giving unnecessary, potentially toxic
treatments to patients, who would not otherwise be offered them,
even in the usual post-operative setting. Our study has shown high
sensitivity (86–92%) and PPVs (90–92%) for the identification of
T3 and T4 tumours by preoperative CT. Furthermore, there is
reasonable correlation between CT-predicted ‘poor prognosis’
T-stage (i.e. T4 and T3c and d) and poor histological group
(PPV¼74–75%). However, the most compelling evidence for CT-
based prognostication comes from the survival analysis. If CT-
predicted T-stage discriminates between good and poor outcome
as well as the accepted pathological criteria (which it does in this
study), then it seems no more unreasonable to use preoperative CT
to guide preoperative treatment, as it does to use pathological
criteria to indicate post-operative therapy. The benefits of
preoperative therapy in colon cancer, although theoretically
persuasive (potential downstaging, greater tolerability), remain
unproven. Reliable preoperative staging is required before any pre-
vs post-operative chemotherapy trial could be set up, and the
results of this relatively small study would require further
validation in a multi-centre setting. Nonetheless, our results
suggest that preoperative CT may be of greater use than simply
the exclusion of distant metastases.
In conclusion, we have demonstrated that preoperative CT can
predict the clinical outcome for ‘good’ and ‘poor’ prognosis
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Figure 9 Kaplan–Meier RFS curves according to CT-predicted overall
PS.
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stumours with the same accuracy as histopathology. Our results
suggest that it is therefore a robust method for stratifying patients
preoperatively, and recognition of poor prognosis tumours
preoperatively may permit investigation into the use of neo-
adjuvant therapy in colon cancer. This will form the basis of a
future clinical trial.
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